For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access insights report from EVERSANA (pharmaphorum's parent company). You can see the ...
The fund bought more USVM, lifting the position to 1.125% of 13F AUM as of December 31, 2025. Top holdings after the filing: IVV: $4.54 billion (6.6% of AUM) AVGO: $2.78 billion (4.0% of AUM) AGG: ...
Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate as the Fed rate changes. CNBC Select will update as changes are made public. High-yield ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results